---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-007918"
form_type: "8-K"
ticker: "EDSA"
cik: "0001540159"
company_name: "Edesa Biotech, Inc."
filed_at: "2025-12-12T23:59:59+00:00"
generated_at: "2026-05-16T13:21:03.917844+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Edesa Biotech increases ATM offering capacity to $2.26M; discloses prior sales of $3.72M

## Summary
- Prospectus supplement filed to increase max aggregate offering under ATM to $2,262,508.
- Prior sales: $3.72M under Sept 2025 prospectus and $837K under Oct 2024 supplement.
- Legal opinion of Fasken Martineau DuMoulin LLP regarding validity of shares attached.

## SEC filing metadata
- accession: 0001171843-25-007918
- form_type: 8-K
- ticker: EDSA
- cik: 0001540159
- company_name: Edesa Biotech, Inc.
- filed_at: 2025-12-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1540159/000117184325007918/0001171843-25-007918-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1540159/000117184325007918/f8k_121225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-007918
- JSON: https://secwatch.observer/filing/0001171843-25-007918.json
- Plain text: https://secwatch.observer/filing/0001171843-25-007918.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.